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Abstract
Background: Scanned ion beam therapy of intra-fractionally moving tumors requires motion mitigation. GSI proposed 
beam tracking and performed several experimental studies to analyse the dosimetric precision of the system for 
scanned carbon beams.
Methods: A beam tracking system has been developed and integrated in the scanned carbon ion beam therapy unit 
at GSI. The system adapts pencil beam positions and beam energy according to target motion.
Motion compensation performance of the beam tracking system was assessed by measurements with radiographic 
films, a range telescope, a 3D array of 24 ionization chambers, and cell samples for biological dosimetry. Measurements 
were performed for stationary detectors and moving detectors using the beam tracking system.
Results: All detector systems showed comparable data for a moving setup when using beam tracking and the 
corresponding stationary setup. Within the target volume the mean relative differences of ionization chamber 
measurements were 0.3% (1.5% standard deviation, 3.7% maximum). Film responses demonstrated preserved lateral 
dose gradients. Measurements with the range telescope showed agreement of Bragg peak depth under motion 
induced range variations. Cell survival experiments showed a mean relative difference of -5% (-3%) between 
measurements and calculations within the target volume for beam tracking (stationary) measurements.
Conclusions: The beam tracking system has been successfully integrated. Full functionality has been validated 
dosimetrically in experiments with several detector types including biological cell systems.
Background
At GSI Helmholtzzentrum für Schwerionenforschung
(GSI) more than 430 patients with tumors mainly in the
head and neck area were treated with a rasterscanned
carbon beam [1,2]. For treatment of respiration-influ-
enced tumors motion mitigation techniques will be
required because the interference of target motion and
scanned beam delivery potentially leads to mis-dosage,
typically referred to as interplay [3,4]. Beam gating [5],
rescanning [3], and beam tracking [6,7] have been pro-
posed to adequately irradiate moving targets with
scanned particle beams.
Tracking has been suggested in different technical ways
and for different treatment modalities. For photon radio-
therapy tracking is implemented clinically in the
Cyberknife Synchrony system [8]. Adaptations are pri-
marily in the lateral dimensions and can therefore also be
performed by dynamically adapting the multi-leaf colli-
mator of a standard linear accelerator [6]. In contrast to
photon therapy, particle therapy requires modulation not
only in the lateral direction but also in the radiological
depth because organ motion potentially changes densi-
ties in the beam paths and therefore the particle ranges
[9].
A feasibility study at GSI showed that the rasterscan
beam delivery system can be extended to treat moving
tumours by beam tracking by adapting the position of
rasterpoints [10]. Lateral adaptation is performed by real-
time changes of the scanning magnet settings. Compen-
sation of changes in radiological depth is carried out by a
passive energy modulation system installed proximal to
the isocenter. The system consists of two opposing
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absorber wedges that are opened (closed) by fast linear
motors when the radiological length has to be increased
(decreased). Within the feasibility study, individual com-
pensation components were tested independently. To
allow simultaneous lateral and range adaptation the ini-
tial prototype system has been redesigned, fully inte-
grated into the therapy control system (TCS), and
technically commissioned [7,11].
The data in this report present a full set of dosimetric
studies performed with the most recent version of the
tracking system. Earlier investigations focused on indi-
vidual components of the beam tracking system [10], its
technical performance [11], as well as initial dosimetric
measurements [7]. We utilized our experience from pre-
vious, independent measurement series to determine the
a c c u r a cy  o f  3 D  d o s e  d i s t r i b u t i o n s  as  w e l l  a s  t h e  R B E -
effective dose, to investigate the implications of beam
tracking for volumes proximal to the target volume, and
to perform detailed measurements with respect to range
adaptation. In order to examine the beam tracking per-
formance independent from possible ambiguities of tar-
get motion detection an accurate industrial motion
sensor was employed to monitor the motion trajectories
of moving phantoms.
Methods
Experimental setup
Four different detector types were used to test dose deliv-
ery by the integrated beam tracking system: radiographic
films, a range telescope, an array of 24 ionization cham-
bers, and biological cell samples. This combination was
selected to measure the most important characteristics of
particle dose distributions. (i) Radiographic film mea-
surements provide high spatial resolution at a specific
depth, (ii) the range telescope enables precision depth
dose distribution measurements, (iii) the array of ioniza-
tion chambers facilitates 3D measurements, and (iv) the
biological cell samples allow judgment of the validity of
the RBE-weighted dose.
The experimental setup is shown in fig. 1. Besides the
integrated beam tracking system, a sliding table was used
to induce target motion. The motion was orthogonal to
the beam direction, one-dimensional (left-right in beam's
eye view), sinusoidal with an adjustable amplitude and
period, and had a random starting point (motion phase)
(details in tab. 1). Motion monitoring of the sliding table
was performed with a laser triangulation displacement
sensor [11]. In order to generate motion-induced varia-
tions in particle range, a stationary, ramp-shaped
absorber was placed proximal of the sliding table (fig. 1a).
If the particle beam position is adapted left-right to com-
pensate lateral target motion the beam penetrates this
ramp-shaped absorber at different positions with differ-
ent thicknesses in comparison to the reference scenario.
Compensation of these thickness changes had to be per-
formed with the energy modulation system (see 4D treat-
ment planning details by Bert & Rietzel [12]). In
principle, this setup represents relative motion of differ-
ent densities within a treatment field, for example lung
tumors and ribs even though ribs might produce more
discrete range changes.
The setup for the measurements with the 24 pin-point
ionization chamber array (IC03, Wellhöfer, Schwarzen-
bruck, Germany), the radiographic films (Kodak X Omat
V, Kodak GmbH, Stuttgart, Germany), as well as for the
measurements with the cell samples is shown in fig. 1a.
Film and cell sample detector were used in a single irradi-
ation. One radiographic film was installed stationary dis-
tal to the ramp shaped absorber; the second, moving film
was placed on the sliding table proximal to the container
of the cell sample probe.
Chinese Ovary cells (CHO-K1) were used to measure
cell inactivation based on the assay by Puck and Marcus
[13] as described by Gemmel et al. [14]. The CHO-cells
w e r e  s e e d e d  i n t o  M i c r o W e l l ™  p l a t e s  ( N u n c ,  R o s k i l d e ,
Denmark, 12 × 8 wells per plate, diameter per well: 7 mm,
grid spacing: ~9 mm, 10000 cells per well). MicroWell™
plates were chosen because they provide adequate cell
culture conditions and with respect to biological dosime-
try they allow good sampling of data points in the lateral
plane (see fig. 1b). Two MicroWell™ plates were stacked in
upright position in a container filled with medium to
achieve measurements at two different points in depth
(±4.5 mm from the target center). Due to limited incuba-
tor space ~10 wells were analyzed per plate (marked in
fig. 1b).
Data acquisition and setup of the 24 pin-point ioniza-
tion chambers were performed as described by Karger et
al. [15]. The chambers were arranged within a volume of
~60 × 70 × 15 mm3 fixed on a polymethylmethacrylate
(PMMA) block in three different heights to avoid dosim-
etric shadowing effects (see fig. 1c). The complete block
can be positioned by mechanical stages within a water
tank (MP3, PTW, Freiburg, Germany) that was placed on
the sliding table. We measured at two different positions
(see fig. 1c, with bold circles indicating the 24 chambers
of one array position) to have a higher spatial resolution.
This results in 48 data points of which 33 are positioned
within the target volume that is indicated by the rectangle
in fig. 1c.
A second setup (fig. 1d) was used for depth dose distri-
bution (DDD) measurements with a range telescope [16]
to assess the precision of range compensation. The range
telescope determines the DDD by measuring the charge
ratio of the distal (I2) and a proximal (I1) ionization cham-
ber for different water thicknesses L (see fig. 1d and [17]).
At each water thickness level and for three consecutive
measurements the charge generated in the ionizationBert et al. Radiation Oncology 2010, 5:61
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chambers was accumulated for an accelerator pulse of 2.2
s duration (~1.5·107 particles). As described above, range
changes were induced by deflecting the beam laterally
over the stationary ramp absorber. Because lateral
Figure 1 Experimental setup. Schematic drawing of the experimental setups. For film, cell sample, and ionization chamber experiments the target 
was moved on a sliding table left-right in beam's eye view (BEV). Proximal to the target, a ramp-shaped absorber was installed stationary such that 
lateral compensation induces range changes since the beam traverses this absorber at a different thickness. Films were positioned stationary directly 
behind the absorber as well as on the sliding table. The 24 ionization chambers are mounted within a water tank that is positioned on the sliding table. 
Data were acquired at two array positions as shown in (c) as bold and regular circles. For cell survival measurements two MicroWell plates where used 
with cell survival measurements performed at the positions indicated in (b). (d) For range validation, a range telescope in the target area was used to 
measure the relative ionization of two parallel-plate ionization chambers (I1 and I2). Range changes were induced as described in (a).
Table 1: Treatment plan and delivery details for the different experiments.
experiment film response/cell samples pin-point ionization chamber array DDD
target volume [WxHxD mm3] 28 × 45 × 23 36 × 20 × 50 single beam
depth range [MeV/u] 265 - 299 267 - 330 400
number of iso-energy slices 18 21 -
number of raster points 3444 5946 1
grid spacing [mm] 2.5 2 -
scan path up-down up-down -
beam spot FWHM [mm] 7.5 5.6 2.3
peak-to-peak amplitude lateral/
radiological depth [mm/mm water]
40/15.2 30/11.4 40/15.2
motion period [s] ~ 3 ~ 3.4 ~ 3
target dose 6 GyE (3.3 Gy at target 
center)
2 Gy -
irradiation time [s] ~ 140 ~ 150 -Bert et al. Radiation Oncology 2010, 5:61
http://www.ro-journal.com/content/5/1/61
Page 4 of 9
motion was continuous during the measurements the
induced range changes were uncorrelated to the water
thickness of the range telescope.
Treatment plans and delivery
Reference treatment plans were optimized with our in-
house treatment planning system (TReatment planning
for Particles, TRiP) [12,18,19]. For each setup a different
plan was used; plan details are listed in table 1. For all
detectors, measurements were performed for (i) a sta-
tionary setup (reference), (ii) a moving setup without
beam tracking (not for cell sample detector), and (iii) a
moving setup with beam tracking. The experiment with
the CHO-cell cultures was independently repeated three
times. Each time a stationary setup and a moving setup
with beam tracking was irradiated. In addition to the irra-
diated containers identical containers were prepared that
served as controls for stationary and moving setup, i.e.
went through the same procedures as the irradiated con-
tainers but were not exposed to irradiation. After the irra-
diation the cell survival in the wells marked in figure 1b
was determined by trypsinizing, counting, and re-seeding
(three times per well) the cells at an appropriate number.
After an incubation time of 7 days the colonies were
stained and counted for each well.
Beam tracking parameters were derived analytically.
For a given peak-to-peak motion amplitude the minimum
and maximum voltages of the displacement sensor were
measured prior to the experiments and stored in the
treatment control system. During beam delivery, the con-
trol system converted the voltage from the displacement
sensor into lateral motion compensation parameters rela-
tive to these calibration measurements. Similarly, com-
pensation parameters for the radiological depth were
determined by multiplying the lateral compensation
parameters with the slope of the ramp absorber (0.38 mm
water-equivalent for 1 mm left-right motion). To over-
come the response of range modulation which is ~25 ms
for 5 mm water-equivalent (WE) range shift, linear
motion prediction was used as reported by Saito et al.
[11].
Data analysis
Data analysis was performed relative to the stationary ref-
erence results for each measurement series.
Film response
Films were processed as reported by Spielberger et al.
[20] and evaluated by
• the 2D distribution
• horizontal profiles which are sensitive for detection 
of positional deviations as well as fluctuations in film 
intensity
• analyzing the relative film response in a central 
region of interest (20 × 30 mm2) by mean, standard 
deviation, homogeneity index (defined as 1-standard 
deviation/mean) as well as minimum and maximum 
averaged over a 5 × 5 mm2 area.
Depth dose profiles
Depth dose distributions were analyzed regarding the
depth and height of the Bragg peak. Data points show the
mean results of the three measurements per thickness
level, error bars represent one standard deviation.
Pin-point ionization chambers (absorbed dose)
For the relative dose data of the ionization chamber array,
mean, standard deviation, and maximum deviation of the
relative and the absolute relative dose deviation are
reported. Analysis was performed for all ionization
chambers, the subset of chambers that was positioned
within the target volume, for the left and right penumbra,
as well as for chambers distal of the target volume. To
visualize these four-dimensional data (coordinates are:
BEV left-right, BEV up-down, BEV, relative dose) the rel-
ative dose to each spatial dimension is plotted, i.e. three
two-dimensional graphs.
Biological cells samples (RBE-weighted dose)
The survival data of the three independent experiments
were combined. For each well j mean survival   and the
standard error of the mean survival   where σj is
the standard deviation of the three measured survival lev-
els are reported. Data for irradiation modalities station-
ary and beam tracking are combined to mean survival
 and   and mean standard errors
 and  , respectively. In agreement
with the dose calculation steps in treatment planning we
further convert the survival data into RBE-weighted
doses D RBE by using the linear-quadratic model with lit-
erature data for α and β: 
with α = 0.228 Gy-1 und β = 0.02 Gy-2 according to Wey-
rather et al. [21]. Also for the dose values mean
 and   and standard error 
and   are reported. For quantification of the
beam tracking accuracy we did three comparisons:
C1) Experiment vs. TRiP (stationary): to benchmark 
the accuracy of biological dosimetry in standard con-
ditions, comparing the stationary experimental result 
Sj
SES
j j =
s
3
S
stationary S
tracking
SES
stationary
SES
tracking
D S
RBE =− + ( ) − a
b
a
b b 2 2
2
ln
DRBE
stationary DRBE
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to the prescribed dose as determined by TRiP based 
on the local effect model (LEM III) [22].
C2) Experiment vs. TRiP (beam tracking): experi-
mental results with beam tracking were compared to 
the prescribed dose.
C3) Beam tracking vs. stationary (experimental): 
experimental results with beam tracking were com-
pared to experimental results with a stationary phan-
tom. The mean standard error of this comparison is 
determined by 
.
Data will be presented graphically as 
for each of the three comparisons. Wells in the target vol-
ume and outside of the target volume were also separately
analyzed.
Results
Film response
Results of the film response measurements are shown in
fig. 2. For the stationary setup the irradiation results in a
homogeneous response within the target area of both
films. In case of target motion without beam tracking
interplay distorts the film response distribution in the
distal (moving) film. The response in the proximal (sta-
tionary) film is comparable to the response of the station-
ary measurement. With beam tracking, the results are
vice versa: The result of the moving film is comparable to
the stationary irradiation because beam adaptation com-
pensates target motion. An "inverse interplay effect"
caused by beam tracking of the moving target causes a
deteriorated film response on the stationary film that
resembles the path of the beam as it is adapted to the tar-
get motion. The horizontal profiles at the position indi-
cated by the arrows confirm these results and indicate a
slight shift to the right in BEV of the distal film for beam
tracking in comparison to the stationary irradiation.
Statistical data in table 2 confirm that deviations
between dose deliveries to a stationary target (mean 0.28,
homogeneity 0.97) and to a moving target using beam
tracking (mean 0.28, homogeneity 0.97) are comparable
on the distal (moving) film.
Depth dose profiles
Data of the DDD measurement are plotted in fig. 3. The
influence of target motion on the shape of the Bragg
curve is severe if no motion mitigation is applied. With
beam tracking the DDD is comparable in shape and
height to the stationary experiment. The peak depth is
slightly (< 0.25 mm water-equivalent) shifted towards
greater depth.
Pin-point ionization chambers (absorbed dose)
Results of the ionization chamber array measurements
are displayed in fig. 4. With the exemption of three data
points in BEV left-right (-24 mm, -21 mm, 21 mm), mea-
sured doses for tracking the moving target are within 5%
in comparison to the stationary reference measurement.
Within the target volume (33 of 48 chambers, corre-
sponding to filled symbols in figures 1c and 4) doses
delivered to a moving target with beam tracking deviated
from the doses of a stationary reference irradiation by 0.3
± 1.5% (abs. values: 1.2 ± 0.9%) with -2.7% minimum and
3.7% maximum deviation (details in table 3). A compari-
son of relative doses outside of the target volume indi-
cates a small horizontal shift of measurement setups
between reference and tracking experiment: left penum-
SE SE SE DD D RBE RBE RBE
experimental tracking stationary
= () + ()
22
DS E D RBE RBE ±
Figure 2 Results of proximal and distal film responses. Shown is the normalized optical density. Statistical analysis reported in table 2 was per-
formed within the region of interest indicated by the dashed square. Horizontal profiles are in the direction indicated by the arrows (y = 0).Bert et al. Radiation Oncology 2010, 5:61
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bra mean -13.3% and right penumbra mean + 7.8%. This
shift occurred most likely due to a slight positional differ-
ence of the motion table between experiments translating
into different ionization chamber positions. By minimiz-
ing the dose deviations at interpolated IC positions, a
shift of -0.6 mm was determined.
Biological cells samples (RBE-weighted dose)
Figure 5 shows the results of the CHO-cell experiment.
Both, stationary measurement as well as beam tracking
yield good agreement with the expectation from treat-
ment planning. Largest deviations are seen in wells
located in the lateral field gradient (see also profiles in fig.
5b). The data of the comparisons C1-C3 are shown in fig-
ure 6. The spread of the results around zero is compatible
with the standard errors of the measurements.
Discussion
Beam tracking is one of the options to treat tumors that
are subject to respiratory motion with scanned ion
beams. The presented data demonstrate that beam track-
ing is a feasible and accurate motion mitigation tech-
nique.
Small deviations between data from tracking and sta-
tionary reference irradiations most likely result from the
experimental setup accuracy and the precision of the
detector systems. In case of the cell survival experiments,
the latter is dominating due to the complex cell process-
ing procedure, including several cell handling steps, and
the inherent biological variability. A large deviation in
data points is observed in the survival points at +13.5 mm
(Fig. 5), but this could be due to the limited statistical
power of these experiments (3 independent experiments
only). Concerning modeling of biological effects that have
to be considered for heavy ion irradiation such as carbon
beams the accuracy of the local-effect model for the pri-
mary beam and its fragments in the therapy relevant
energy range has to be considered also for moving tar-
gets. Since our investigation focused on the impact of tar-
get motion and validation of the beam tracking system
rather than validation of the biological modeling we did
not include uncertainties of the model into the compari-
son between experimental and calculated data.
Additional uncertainties are related to induction and
measurement of motion trajectories, discretization of the
radiological depth compensation, and potentially the
temporal response of the system. Since compensation
parameters were determined relative to the voltage level
measured by the displacement sensor, a shift of the
motion table center (mean voltage level, i.e. compensa-
tion = 0) with respect to the isocenter leads to a small
shift of the dose distribution. This effect is observable in
the profiles of film measurements (fig. 2, distal film, beam
tracking vs. stationary) and in the measurements with the
pinpoint-ionization chambers (detected shift of 0.6 mm).
The magnitude of each shift is comparable to the 0.75
mm shift reported previously [7]. In principle this align-
ment uncertainty could be further reduced by a more
precise motion phantom and improved alignment tools
for the heavy water tank (~25 kg). Positioning accuracy of
the MicroWell plates is estimated to be less than 1 mm
and comprises both the alignment uncertainty of the con-
Table 2: Statistical analysis for the film response (normalized optical density).
proximal distal
stat. mov. comp. stat. mov. Comp.
mean 0.38 0.37 0.26 0.28 0.20 0.28
SD 0.01 0.01 0.02 0.01 0.02 0.01
h o m o g e n e i t y 0 . 9 80 . 9 80 . 9 30 . 9 70 . 9 00 . 9 7
minimum5 × 5 0.36 0.34 0.21 0.24 0.17 0.25
maximum5 × 5 0.39 0.38 0.3 0.29 0.23 0.28
Figure 3 Results of the range telescope measurements. Measure-
ments with a stationary setup, a moving setup without compensation, 
and a moving setup with compensation were performed. Mean and 
one standard deviation are plotted. The data points are connected to 
guide the eye.Bert et al. Radiation Oncology 2010, 5:61
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tainer and the positioning precision of the plates within
the container. Precision of the radiological depth com-
pensation with the energy modulation system is currently
limited by digitization to 0.16 mm water-equivalence for
communication between therapy control system and con-
troller of the energy modulation system [11]. At least
parts of the measured deviation in Bragg-peak depth
(~250 μm) can be attributed to this technical limitation.
However, in comparison to typical range uncertainties
[17] this residual deviation is small; nonetheless it would
be possible to decrease the step size by improving the
communication if required by future applications. The
temporal response of the system was studied in detail by
Saito et al. [11]. For lateral compensation the system
response is below 1 ms which is much faster than typical
irradiation times of 10 ms per spot and thus has a negligi-
ble impact on the experimental results. Range compensa-
tion is slower. A systematic communication delay of 16
ms plus a mechanical motion delay of for example 11 ms
for 5 mm WE range change is required. Since we used
motion prediction for the range adaptation component
the limited response time of the range modulation device
can be mitigated. The results of the depth dose distribu-
tion measurements shown in fig. 3 show the feasibility of
accurate range adaptation.
Possible systematic uncertainties such as film developer
conditions, differences between film batches, entrance
position of the range telescope, W-value, and positioning
of ionization chambers within the water phantom are not
relevant because beam tracking performance was com-
pared to stationary reference measurements within the
same experimental series. Random uncertainties are
present in film analysis (1 mm pixel size in digitization
process, 3 mm FWHM beam spot for coordinate system),
in the positioning accuracy of the range telescope (10 μm
stepping motor step size) [16], and due to accumulated
background in the ionization chamber measurements
which Karger et al. reported to be 0.5 - 1 mGy/min lead-
ing to ~ 0.1% uncertainty in our measurements (2 Gy in
~2.5 min) [15]. In addition, the mechanical precision of
the ramp-shaped absorber, the container of the cell sam-
ples as well as the wedge-system of the energy modula-
tion system has to be considered which can be estimated
to be in the range of 0.1-0.2 mm (each). Biological vari-
ability leads to mean standard errors of 4% and 5% for the
moving and the stationary setup which is comparable to
previous cell survival experiments [14].
Figure 4 Results of the pinpoint ionization chamber array measurements. Shown are the projections of the beam tracking data measured by 
the ionization chambers. Data points are relative to the stationary reference irradiation. The dashed line indicates the nominal dose level; the two dot-
ted horizontal lines indicate the 5% acceptance level, the shaded area indicates the target volume.
Table 3: Statistical analysis for the ionization chamber array measurements.
IC position Mean SD abs. mean abs SD minimum maximum
t a r g e t  v o l u m e 0 . 31 . 51 . 20 . 9- 2 . 73 . 7
left penumbra -13.3 2.3 13.3 2.3 -15.8 -10.5
r i g h t  p e n u m b r a 7 . 80 . 17 . 80 . 17 . 87 . 9
distal edge -1.5 5.1 4.1 3.1 -8.9 3.3
position A 0.8 1.6 1.4 1.0 -2.5 3.7
position B -0.2 1.3 1.0 0.8 -2.7 2.3
All values denote the relative dosimetric deviation between motion compensated and the stationary reference measurement in %. Position 
A refers to chamber positions indicated by solid lines, position B to chamber positions indicated by thin lines in fig. 1c.Bert et al. Radiation Oncology 2010, 5:61
http://www.ro-journal.com/content/5/1/61
Page 8 of 9
For future clinical use of a beam tracking system, larger
uncertainties can be expected due to well-known devia-
tions resulting from patient positioning [23] range devia-
tions [17], and motion detection. The impact of these
uncertainties on beam tracking will be subject of further
research.
In the current status, the beam tracking system is capa-
ble to irradiate treatment plans of e.g. liver cancer
patients that do not show large range variations. To fur-
ther advance towards clinical use of ion beam tracking
more work is required mainly concerning accurate and
precise motion detection, robust treatment planning, and
potentially with respect to an improved range modula-
tion system as recently proposed by Chaudhri et al. [24].
It has been reported by several authors that tumor
motion characteristics change over the course of treat-
m e n t  [ 9 , 2 5 ] .  F e a s i b l e  m i t i g a t i o n  s t r a t e g i e s  h a v e  t o  b e
developed because such changes might alter the dose dis-
tribution of dedicated 4D treatment plans applied by
beam tracking. In the next step, serial 4DCT patient data
will be analyzed and possible techniques to mitigate
interfractional changes will be investigated. Besides ade-
quate target dosage, effective doses deposited proximal of
the target could be considered. As demonstrated with
f i l m  e x p e r i m e n t s ,  i f  t a r g e t  m o t i o n  i s  c o m p e n s a t e d  b y
beam tracking inverse interplay effects in proximal
regions can lead to over-dosage [4] that should ideally be
considered for dose distributions of proximal tissues or
even organs-at-risk.
Adequate performance of the motion monitoring sys-
tem will be as important as the technical precision of the
beam tracking system. Several research groups are work-
ing on precise motion monitoring and motion prediction
techniques; motion detection in the < 2 mm range has
recently been reported [26,27]. Sawant et al. achieved a
geometrical precision of < 1 mm for a multi-leaf collima-
tor based tracking system that obtains motion informa-
tion from a Calypso system [26]. Lin et al. used principal
component analysis to track lung tumors in fluoroscopic
images and reported mean localization errors of less than
1 mm with a maximum of 2.5 mm in 12 patients [27]. For
systems that rely on implanted fiducials, like the electro-
magnetic Calypso system [28] or fluoroscopy tracking
based on radio-opaque markers [8], the compatibility
with ion beams has to be evaluated with respect to func-
tionality of the beacon transponders in high-LET fields
and considering the dosimetric effect. Considering the
data reported for motion detection, it seems feasible to
Figure 5 Results of the biological dosimetry. Nominal vs. measured survival of the CHO-cell irradiations. (a) The 2D color-wash distribution indi-
cates the survival level predicted by treatment planning. The circles indicate the scored MicroWell plate positions. (b) Along the directions indicated 
as arrows in (a) profiles are taken showing experimental vs. calculated data (solid line). The experimental data points show the mean survival level of 
the three measurements, error bars indicate the standard error. The shaded area indicates the target volume.
Figure 6 Result of the RBE-effective dose comparisons. Each data 
point is the mean difference in RBE-effective dose. Error bars indicate 
the standard error. To exclude the influence of well positions in dose 
gradients, a separate analysis for wells within the target volume was 
performed.Bert et al. Radiation Oncology 2010, 5:61
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detect, model, and predict target motion in quasi real-
time sufficiently accurate to allow tracking with particle
beams.
Conclusions
Ion beam tracking has been fully integrated in the treat-
ment control system at GSI. The system allows target
motion detection and simultaneous lateral and radiologi-
cal depth compensation of target motion in quasi real-
time. Validation measurements were performed with
radiographic films, a range telescope, an array of ioniza-
tion chambers, and CHO-cell samples to incorporate the
biological effect of carbon ions. Tracking target motion
with a scanned particle beam results in dose distributions
that are comparable to stationary reference irradiations.
To further advance towards clinical use of beam tracking,
research has to be performed with respect to motion
detection as well as robust 4D treatment planning.
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